Trials / Unknown
UnknownNCT05508295
Long COVID-19 and MAB Study
Setting up a Community Based Patient Cohort to Understand Long COVID: Monoclonal Antibody and Post-Infection COVID Vaccine Administration as the FOCI
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- MultiCare Health System Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will be observational only. It will provide real-world evidence generated from a representative and large-scale COVID patient base. The adoption, pilot testing and use of NIH PROs among viral tested patients with research purpose on long COVID will be unique and innovative. With the existing and proven scientific rigor, NIH PRO system will be adopted, then modified and tailored to form the long hauler specific, comprehensive instrument, helping generalize future knowledge regarding COVID-infected patients.
Conditions
Timeline
- Start date
- 2023-06-20
- Primary completion
- 2023-11-30
- Completion
- 2024-01-31
- First posted
- 2022-08-19
- Last updated
- 2023-06-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05508295. Inclusion in this directory is not an endorsement.